Anthem Biosciences Ltd.
ANTHEM Share PricePharmaceuticals & Drugs
₹699.45
12.4 (1.8%)
As on December 12, 2025
Exchange Scrips: BSE544449NSEANTHEMISININE0CZ201020
Market Cap ₹ 39,251 Cr
P/E Ratio 86.66
Dividend Yield N/A
Performance
Market performance
Open687.1
High700.7
Volumes4,93,876
Prev699.45
Low675
As on2025-12-12
Historical performance
1 Year High873.5
3 Year High873.5
5 Year High873.5
1 Year Low620
3 Year Low620
5 Year Low620
Fundamentals
Company Valuation
Market Cap (₹Cr)
39,251
Face Value (₹)
2
P/E Ratio
86.66
Dividend Yield
N/A
Investment Returns
1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 667.47 | Bullish |
| 10-DMA | 662.94 | Bullish |
| 20-DMA | 652.07 | Bullish |
| 50-DMA | 701.52 | Bearish |
| 100-DMA | 748.73 | Bearish |
| 200-DMA | --- |
Shareholding Pattern
| Field | Sep-2025 | Jul-2025 |
|---|---|---|
| Promoters | 9 | 9 |
| Foreign Investors | --- | --- |
| Domestic Investors | 9 | 9 |
| Public Investors | 217672 | 825835 |
| Government | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 86.66.
- 3Y Stock Price CAGR of the stock is None.
- The stock has a beta of 1.4.
- In the last financial year, the company had an EBITDA of ₹7568 Million.
- The company generated revenue of ₹18446 Million in the previous financial year.
Anthem Biosciences Ltd.
699.4512.4 (1.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 957691.5
No. of Shares: 1369 (Approx)
Performance:-4.2%
P/L: ₹-42308.5
Top Gainers
| Symbol | Change% |
|---|---|
| MAHAPEXLTD | 95.24(20%) |
| VIPULLTD | 10.24(20%) |
| TVVISION | 7.77(20%) |
| TARIL | 280.2(17%) |
| WALCHANNAG | 175.53(14%) |
Top Losers
| Symbol | Change% |
|---|---|
| REFEX | 254.9(-20%) |
| VLSFINANCE | 299.45(-10%) |
| BALAXI | 30.06(-9%) |
| VLEGOV | 21.01(-9%) |
| KSR | 17.33(-9%) |
| ASMS | 12.2(-8%) |
| VINNY | 1.28(-7%) |
| RAJSREESUG | 37.79(-6%) |
Peer Comparison
Get Your Portfolio Reviewed
